Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Research

Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors

Authors: Julia JM Eekels, Sophie Sagnier, Dirk Geerts, Rienk E Jeeninga, Martine Biard-Piechaczyk, Ben Berkhout

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Autophagy is a cellular process leading to the degradation of cytoplasmic components such as organelles and intracellular pathogens. It has been shown that HIV-1 relies on several components of the autophagy pathway for its replication, but the virus also blocks late steps of autophagy to prevent its degradation. We generated stable knockdown T cell lines for 12 autophagy factors and analyzed the impact on HIV-1 replication. RNAi-mediated knockdown of 5 autophagy factors resulted in inhibition of HIV-1 replication. Autophagy analysis confirmed a specific defect in the autophagy pathway for 4 of these 5 factors. We also scored the impact on cell viability, but no gross effects were observed. Upon simultaneous knockdown of 2 autophagy factors (Atg16 and Atg5), an additive inhibitory effect was scored on HIV-1 replication. Stable knockdown of several autophagy factors inhibit HIV-1 replication without any apparent cytotoxicity. We therefore propose that targeting of the autophagy pathway can be a novel therapeutic approach against HIV-1
Appendix
Available only for authorised users
Literature
1.
go back to reference Mizushima N, Klionsky DJ: Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007, 27: 19-40. 10.1146/annurev.nutr.27.061406.093749PubMedCrossRef Mizushima N, Klionsky DJ: Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007, 27: 19-40. 10.1146/annurev.nutr.27.061406.093749PubMedCrossRef
2.
go back to reference Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al.: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003, 112: 1809-1820.PubMedPubMedCentralCrossRef Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al.: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003, 112: 1809-1820.PubMedPubMedCentralCrossRef
3.
go back to reference Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, et al.: Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007, 128: 931-946. 10.1016/j.cell.2006.12.044PubMedCrossRef Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, et al.: Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007, 128: 931-946. 10.1016/j.cell.2006.12.044PubMedCrossRef
4.
go back to reference Kotoulas OB, Kalamidas SA, Kondomerkos DJ: Glycogen autophagy in glucose homeostasis. Pathol Res Pract 2006, 202: 631-638. 10.1016/j.prp.2006.04.001PubMedCrossRef Kotoulas OB, Kalamidas SA, Kondomerkos DJ: Glycogen autophagy in glucose homeostasis. Pathol Res Pract 2006, 202: 631-638. 10.1016/j.prp.2006.04.001PubMedCrossRef
5.
go back to reference Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, et al.: In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32: 227-239. 10.1016/j.immuni.2009.12.006PubMedPubMedCentralCrossRef Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, et al.: In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32: 227-239. 10.1016/j.immuni.2009.12.006PubMedPubMedCentralCrossRef
6.
go back to reference Espert L, Codogno P, Biard-Piechaczyk M: Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med 2007, 85: 811-823. 10.1007/s00109-007-0173-6PubMedCrossRef Espert L, Codogno P, Biard-Piechaczyk M: Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med 2007, 85: 811-823. 10.1007/s00109-007-0173-6PubMedCrossRef
7.
go back to reference Shoji-Kawata S, Levine B: Autophagy, antiviral immunity, and viral countermeasures. Biochim Biophys Acta 2009, 1793: 1478-1484. 10.1016/j.bbamcr.2009.02.008PubMedPubMedCentralCrossRef Shoji-Kawata S, Levine B: Autophagy, antiviral immunity, and viral countermeasures. Biochim Biophys Acta 2009, 1793: 1478-1484. 10.1016/j.bbamcr.2009.02.008PubMedPubMedCentralCrossRef
8.
go back to reference Talloczy Z, Virgin HW, Levine B: PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2006, 2: 24-29.PubMedCrossRef Talloczy Z, Virgin HW, Levine B: PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2006, 2: 24-29.PubMedCrossRef
9.
go back to reference Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, et al.: HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007, 1: 23-35. 10.1016/j.chom.2006.12.001PubMedCrossRef Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, et al.: HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007, 1: 23-35. 10.1016/j.chom.2006.12.001PubMedCrossRef
10.
go back to reference Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, et al.: Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 2005, 3: e156. 10.1371/journal.pbio.0030156PubMedPubMedCentralCrossRef Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, et al.: Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 2005, 3: e156. 10.1371/journal.pbio.0030156PubMedPubMedCentralCrossRef
11.
go back to reference Zhou Z, Jiang X, Liu D, Fan Z, Hu X, Yan J, et al.: Autophagy is involved in influenza A virus replication. Autophagy 2009, 5: 321-328. 10.4161/auto.5.3.7406PubMedCrossRef Zhou Z, Jiang X, Liu D, Fan Z, Hu X, Yan J, et al.: Autophagy is involved in influenza A virus replication. Autophagy 2009, 5: 321-328. 10.4161/auto.5.3.7406PubMedCrossRef
12.
go back to reference Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ramer PC, et al.: Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 2009, 6: 367-380. 10.1016/j.chom.2009.09.005PubMedPubMedCentralCrossRef Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ramer PC, et al.: Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 2009, 6: 367-380. 10.1016/j.chom.2009.09.005PubMedPubMedCentralCrossRef
13.
go back to reference Denizot M, Varbanov M, Espert L, Robert-Hebmann V, Sagnier S, Garcia E, et al.: HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008, 4: 998-1008.PubMedCrossRef Denizot M, Varbanov M, Espert L, Robert-Hebmann V, Sagnier S, Garcia E, et al.: HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008, 4: 998-1008.PubMedCrossRef
14.
go back to reference Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al.: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006, 116: 2161-2172. 10.1172/JCI26185PubMedPubMedCentralCrossRef Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al.: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006, 116: 2161-2172. 10.1172/JCI26185PubMedPubMedCentralCrossRef
16.
go back to reference Espert L, Varbanov M, Robert-Hebmann V, Sagnier S, Robbins I, Sanchez F, et al.: Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009, 4: e5787. 10.1371/journal.pone.0005787PubMedPubMedCentralCrossRef Espert L, Varbanov M, Robert-Hebmann V, Sagnier S, Robbins I, Sanchez F, et al.: Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009, 4: e5787. 10.1371/journal.pone.0005787PubMedPubMedCentralCrossRef
17.
go back to reference Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, et al.: Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 2009, 186: 255-268. 10.1083/jcb.200903070PubMedPubMedCentralCrossRef Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, et al.: Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 2009, 186: 255-268. 10.1083/jcb.200903070PubMedPubMedCentralCrossRef
18.
go back to reference Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al.: Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319: 921-926. 10.1126/science.1152725PubMedCrossRef Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al.: Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319: 921-926. 10.1126/science.1152725PubMedCrossRef
19.
go back to reference Eekels JJ, Geerts D, Jeeninga RE, Berkhout B: Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors. Antiviral Res 2011, 89: 43-53. 10.1016/j.antiviral.2010.11.005PubMedCrossRef Eekels JJ, Geerts D, Jeeninga RE, Berkhout B: Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors. Antiviral Res 2011, 89: 43-53. 10.1016/j.antiviral.2010.11.005PubMedCrossRef
20.
go back to reference Campbell GR, Spector SA: Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011, 286: 18890-18902. 10.1074/jbc.M110.206110PubMedPubMedCentralCrossRef Campbell GR, Spector SA: Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011, 286: 18890-18902. 10.1074/jbc.M110.206110PubMedPubMedCentralCrossRef
21.
go back to reference Coley W, Kehn-Hall K, Van DR, Kashanchi F: Novel HIV-1 therapeutics through targeting altered host cell pathways. Expert Opin Biol Ther 2009, 9: 1369-1382. 10.1517/14712590903257781PubMedPubMedCentralCrossRef Coley W, Kehn-Hall K, Van DR, Kashanchi F: Novel HIV-1 therapeutics through targeting altered host cell pathways. Expert Opin Biol Ther 2009, 9: 1369-1382. 10.1517/14712590903257781PubMedPubMedCentralCrossRef
22.
go back to reference Arhel N, Kirchhoff F: Host proteins involved in HIV infection: new therapeutic targets. Biochim Biophys Acta 2010, 1802: 313-321.PubMedCrossRef Arhel N, Kirchhoff F: Host proteins involved in HIV infection: new therapeutic targets. Biochim Biophys Acta 2010, 1802: 313-321.PubMedCrossRef
23.
go back to reference Chakrama FZ, Seguin-Py S, Le Grand JN, Fraichard A, Delage-Mourroux R, Despouy G, et al.: GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy 2010, 6: 495-505. 10.4161/auto.6.4.11819PubMedCrossRef Chakrama FZ, Seguin-Py S, Le Grand JN, Fraichard A, Delage-Mourroux R, Despouy G, et al.: GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy 2010, 6: 495-505. 10.4161/auto.6.4.11819PubMedCrossRef
24.
go back to reference Eekels JJ, Pasternak AO, Schut AM, Geerts D, Jeeninga RE, Berkhout B: A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation. Gene Ther Eekels JJ, Pasternak AO, Schut AM, Geerts D, Jeeninga RE, Berkhout B: A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation. Gene Ther
25.
go back to reference Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003, 34: 263-264. 10.1038/ng1173PubMedCrossRef Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003, 34: 263-264. 10.1038/ng1173PubMedCrossRef
26.
go back to reference Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, et al.: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4: 495-504. 10.1016/j.chom.2008.10.004PubMedCrossRef Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, et al.: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4: 495-504. 10.1016/j.chom.2008.10.004PubMedCrossRef
27.
go back to reference Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, et al.: Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010, 285: 10850-10861. 10.1074/jbc.M109.080796PubMedPubMedCentralCrossRef Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, et al.: Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010, 285: 10850-10861. 10.1074/jbc.M109.080796PubMedPubMedCentralCrossRef
28.
go back to reference Ito S, Koshikawa N, Mochizuki S, Takenaga K: 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol 2007, 31: 261-268.PubMed Ito S, Koshikawa N, Mochizuki S, Takenaga K: 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol 2007, 31: 261-268.PubMed
29.
go back to reference Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008, 68: 1485-1494. 10.1158/0008-5472.CAN-07-0562PubMedCrossRef Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008, 68: 1485-1494. 10.1158/0008-5472.CAN-07-0562PubMedCrossRef
30.
go back to reference Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A: Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007, 14: 500-510. 10.1038/sj.cdd.4402039PubMedCrossRef Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A: Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007, 14: 500-510. 10.1038/sj.cdd.4402039PubMedCrossRef
31.
go back to reference Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009, 16: 761-771. 10.1245/s10434-008-0260-0PubMedCrossRef Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009, 16: 761-771. 10.1245/s10434-008-0260-0PubMedCrossRef
32.
go back to reference Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, et al.: Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 2008, 112: 389-403. 10.1007/s10549-007-9873-4PubMedCrossRef Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, et al.: Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 2008, 112: 389-403. 10.1007/s10549-007-9873-4PubMedCrossRef
33.
go back to reference Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM: Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006, 3: 715-719. 10.1038/nmeth924PubMedCrossRef Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM: Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006, 3: 715-719. 10.1038/nmeth924PubMedCrossRef
34.
go back to reference Eggink D, Baldwin CE, Deng Y, Langedijk JP, Lu M, Sanders RW, et al.: Selection of T1249-resistant human immunodeficiency virus type 1 variants. J Virol 2008, 82: 6678-6688. 10.1128/JVI.00352-08PubMedPubMedCentralCrossRef Eggink D, Baldwin CE, Deng Y, Langedijk JP, Lu M, Sanders RW, et al.: Selection of T1249-resistant human immunodeficiency virus type 1 variants. J Virol 2008, 82: 6678-6688. 10.1128/JVI.00352-08PubMedPubMedCentralCrossRef
35.
go back to reference Garvey EP, Schwartz B, Gartland MJ, Lang S, Halsey W, Sathe G, et al.: Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant. Biochemistry 2009, 48: 1644-1653. 10.1021/bi802141yPubMedCrossRef Garvey EP, Schwartz B, Gartland MJ, Lang S, Halsey W, Sathe G, et al.: Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant. Biochemistry 2009, 48: 1644-1653. 10.1021/bi802141yPubMedCrossRef
36.
go back to reference ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007PubMedCrossRef ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007PubMedCrossRef
37.
go back to reference Peden K, Emerman M, Montagnier L: Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 1991, 185: 661-672. 10.1016/0042-6822(91)90537-LPubMedCrossRef Peden K, Emerman M, Montagnier L: Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 1991, 185: 661-672. 10.1016/0042-6822(91)90537-LPubMedCrossRef
38.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25: 402-408. 10.1006/meth.2001.1262PubMedCrossRef Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25: 402-408. 10.1006/meth.2001.1262PubMedCrossRef
39.
go back to reference Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, Lamers WH: Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 2006, 3: 1-8. 10.1186/1742-4690-3-1CrossRef Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, Lamers WH: Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 2006, 3: 1-8. 10.1186/1742-4690-3-1CrossRef
Metadata
Title
Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors
Authors
Julia JM Eekels
Sophie Sagnier
Dirk Geerts
Rienk E Jeeninga
Martine Biard-Piechaczyk
Ben Berkhout
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-69

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.